Immix Biopharma (IMMX) Insider Trading & Ownership $1.97 -0.07 (-3.43%) As of 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Immix Biopharma (NASDAQ:IMMX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage48.90%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$74,645.00Number OfInsiders Selling(Last 12 Months)0 Get IMMX Insider Trade Alerts Want to know when executives and insiders are buying or selling Immix Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IMMX Insider Buying and Selling by Quarter Immix Biopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/16/2024Carey NgDirectorBuy10,000$1.86$18,600.00 7/24/2024Jason HsuDirectorBuy6,000$2.15$12,900.00 7/18/2024Jason HsuDirectorBuy3,200$2.07$6,624.00 6/7/2024Gabriel S MorrisCFOBuy2,500$2.12$5,300.00 6/7/2024Ilya M RachmanCEOBuy2,600$2.13$5,538.00 6/4/2024Gabriel S MorrisCFOBuy3,300$1.81$5,973.00 5/14/2024Gabriel S MorrisCFOBuy4,500$2.23$10,035.00 5/14/2024Ilya M RachmanCEOBuy4,300$2.25$9,675.00 (Data available from 1/1/2013 forward) IMMX Insider Trading Activity - Frequently Asked Questions Who is on Immix Biopharma's Insider Roster? The list of insiders at Immix Biopharma includes Carey Ng, Gabriel S Morris, Helen C Adams, Ilya M Rachman, Jason Hsu, Magda Marquet, Melissa Jane Buchan, and Sean Senn. Learn more on insiders at IMMX. What percentage of Immix Biopharma stock is owned by insiders? 48.90% of Immix Biopharma stock is owned by insiders. Learn more on IMMX's insider holdings. Which Immix Biopharma insiders have been buying company stock? The following insiders have purchased IMMX shares in the last 24 months: Carey Ng ($44,400.00), Gabriel S Morris ($21,308.00), Helen C Adams ($38,480.00), Ilya M Rachman ($15,213.00), Jason Hsu ($286,294.00), Magda Marquet ($26,710.00), and Melissa Jane Buchan ($49,200.00). How much insider buying is happening at Immix Biopharma? Insiders have purchased a total of 146,400 IMMX shares in the last 24 months for a total of $481,605.00 bought. Immix Biopharma Key ExecutivesDr. Ilya Rachman M.B.A. (Age 51)M.D., MBA, Ph.D., Co-Founder, CEO & Chairman Compensation: $637.5kMr. Gabriel Morris B.A. (Age 37)CFO & Director Compensation: $637.5kMr. Sean Senn J.D.M.B.A., M.Sc., MBA, MSc, Co-FounderDr. Vladimir P. Torchilin D.Sc. (Age 77)MSE, Ph.D., Scientific Co-Founder Mr. Ben H. Lyon J.D.Executive VP & General CounselDr. Graham Ross FFPM (Age 64)M.D., Chief Medical Officer & Head of Clinical Development Mr. Nandan Oza B.S. (Age 62)Head of Chemistry, Manufacturing & Control Dr. David MarksChief Medical Officer of Cell TherapyMr. Gerhard BauerHead of Cell Thearpy Manufacturing More Insider Trading Tools from MarketBeat Related Companies Design Therapeutics Insider Buying COMPASS Pathways Insider Buying Fulcrum Therapeutics Insider Buying Larimar Therapeutics Insider Buying 4D Molecular Therapeutics Insider Buying Ocugen Insider Buying Amylyx Pharmaceuticals Insider Buying Acelyrin Insider Buying DiaMedica Therapeutics Insider Buying Amarin Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:IMMX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immix Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immix Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMMX Stock Alerts